Literature DB >> 15150115

The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation.

Junji Mitsushita1, J David Lambeth, Tohru Kamata.   

Abstract

The activated Ras oncogene can transform various mammalian cells and has been implicated in development of a high population of malignant human tumors. Recent studies suggest that generation of reactive oxygen species such as superoxide and H(2)O(2) is involved in cell transformation by the activated Ras. However, the nature of an oxidase participating in Ras-transformation is presently unknown. Here, we report that Ras oncogene up-regulates the expression of Nox1, a homologue of the catalytic subunit of the superoxide-generating NADPH oxidase, via the mitogen-activated protein kinase kinase-mitogen-activated protein kinase pathway, and that small interfering RNAs designed to target Nox1 mRNA effectively blocks the Ras transformed phenotypes including anchorage-independent growth, morphological changes, and production of tumors in athymic mice. Therefore, we propose that increased reactive oxygen species generation by Ras-induced Nox1 is required for oncogenic Ras transformation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150115     DOI: 10.1158/0008-5472.CAN-03-3909

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  112 in total

Review 1.  ROS in gastrointestinal inflammation: Rescue Or Sabotage?

Authors:  G Aviello; U G Knaus
Journal:  Br J Pharmacol       Date:  2016-03-03       Impact factor: 8.739

2.  Differential induction of reactive oxygen species through Erk1/2 and Nox-1 by FK228 for selective apoptosis of oncogenic H-Ras-expressing human urinary bladder cancer J82 cells.

Authors:  Shambhunath Choudhary; Kusum Rathore; Hwa-Chain Robert Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-15       Impact factor: 4.553

3.  Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species.

Authors:  Courtney G Havens; Alan Ho; Naohisa Yoshioka; Steven F Dowdy
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

4.  Ras-induced ROS upregulation affecting cell proliferation is connected with cell type-specific alterations of HSF1/SESN3/p21Cip1/WAF1 pathways.

Authors:  Maria Zamkova; Natalia Khromova; Boris P Kopnin; Pavel Kopnin
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

5.  Combined incubation of colon carcinoma cells with phorbol ester and mitochondrial uncoupling agents results in synergic elevated reactive oxygen species levels and increased γ-glutamyltransferase expression.

Authors:  Seila Pandur; Chandra Ravuri; Ugo Moens; Nils-Erik Huseby
Journal:  Mol Cell Biochem       Date:  2013-11-27       Impact factor: 3.396

Review 6.  NADPH oxidases in lung health and disease.

Authors:  Karen Bernard; Louise Hecker; Tracy R Luckhardt; Guangjie Cheng; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

7.  Diversity of the angiogenic phenotype in non-small cell lung cancer.

Authors:  Marc R McClelland; Shannon L Carskadon; Liujian Zhao; Eric S White; David G Beer; Mark B Orringer; Allan Pickens; Andrew C Chang; Douglas A Arenberg
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

8.  Reactive oxygen generated by NADPH oxidase 1 (Nox1) contributes to cell invasion by regulating matrix metalloprotease-9 production and cell migration.

Authors:  Masahiro Shinohara; Yoshifumi Adachi; Junji Mitsushita; Mitsuhiro Kuwabara; Atsushi Nagasawa; Saori Harada; Shuichi Furuta; Yugen Zhang; Kajla Seheli; Hitoshi Miyazaki; Tohru Kamata
Journal:  J Biol Chem       Date:  2009-12-17       Impact factor: 5.157

9.  c-Src-mediated phosphorylation of NoxA1 and Tks4 induces the reactive oxygen species (ROS)-dependent formation of functional invadopodia in human colon cancer cells.

Authors:  Davide Gianni; Nicolas Taulet; Céline DerMardirossian; Gary M Bokoch
Journal:  Mol Biol Cell       Date:  2010-10-13       Impact factor: 4.138

10.  Does Mutated K-RAS Oncogene Attenuate the Effect of Sulindac in Colon Cancer Chemoprevention?

Authors:  Photini F S Rice; Kevin G Ehrichs; Mykella S Jones; Hwudarw Chen; Chiu-Hsieh Hsu; Edward R Abril; Raymond B Nagle; David G Besselsen; Jennifer K Barton; Natalia A Ignatenko
Journal:  Cancer Prev Res (Phila)       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.